IDEX Corporation announced today the acquisition of thinXXS Microtechnology AG; a leader in the design, manufacture, and sale of microfluidic components serving the point of care, veterinary, and life science markets.
Located in Zweibrücken, Germany, thinXXS will operate within IDEX Health & Science LLC, part of IDEX’s Health and Science Technologies (HST) segment.
Commenting on the acquisition, IDEX Chairman and Chief Executive Officer Andy Silvernail stated, “thinXXS represents our second acquisition in this space, and with the addition of their advanced technology, our combination makes IDEX Health and Science the market leader in microfluidic technology. thinXXS’ product portfolio is a fantastic fit with IDEX’s core optics and scientific fluidics products and technologies that serve our life science customers. We look forward to thinXXS joining IDEX and we believe the transaction will accelerate our growth prospects in the life science, veterinary and point of care markets.”
Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.
OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.
The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.